Novo Nordisk, which produces popular weight-loss drugs Wegovy and Ozempic, has invested $6.5 billion in the U.S. to ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and ...

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...